Midtrimester abortion using prostaglandin F2alpha, oxytocin, and laminaria.
D000032:Abortion, Therapeutic / Q000009:adverse effects; D000293:Adolescent; D000328:Adult; D000649:Amniocentesis; D000650:Amnion; D003475:Curettage; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007267:Injections; D007275:Injections, Intravenous; D007743:Labor, Obstetric; D008614:Meperidine / Q000008:administration & dosage; D008722:Methods; D010121:Oxytocin / Q000008:administration & dosage / Q000627:therapeutic use*; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012624:Seaweed; D014592:Uterine Hemorrhage / Q000209:etiology; D014839:Vomiting / Q000139:chemically induced
D011453:Prostaglandins; D010121:Oxytocin; D008614:Meperidine